Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 44 min ago
Peer-reviewedCC BY 4.0Scientific Reports

Decoding the anti-adenoviral potential of Ocimum volatile organic compounds: linking chemical fingerprints to molecular targets via docking

Abstract

Ocimum species are globally recognized for their pharmaceutical utility, yet a comparative mapping of their volatile architecture against viral pathogens remains incomplete. This study evaluated the chemical profiles and antiadenoviral (ADV) potential of Ocimum basilicum (Local), O. basilicum var. minimum (French), and O. africanum (Kafory). Volatiles from three extraction techniques; hydrodistillation, n -hexane, and headspace—were analyzed via GC/MS. One hundred fifty-seven compounds were quantified and subjected to Principal Component Analysis (PCA) and clustered heat mapping. Biological efficacy was assessed via IC ₅₀ determination, supported by molecular docking and molecular dynamics (MD) simulations. PCA effectively discriminated against species, with PC1 and PC2 accounting for 88% of total variance. Oxygenated monoterpenes emerged as the dominant class. Notably, O. africanum hydrodistilled oil exhibited exceptional antiadenoviral potency (IC ₅₀ of 1.72 µ g/ml), significantly outperforming the French (IC ₅₀ of 54.26 µ g/ml) and Local varieties. This superior activity is hypothesized to be linked to the high relative abundance of methyl cinnamate and cadinol, while in silico molecular docking predicted 1,3-dimethyladamantane as a key potential bioactive candidate. MD trajectories (RMSD, RMSF, Rg, and SASA) support the hypothesis that this ligand forms a stable, rigid complex with the viral protein, effectively reducing structural flexibility. This study establishes a high-resolution chemical-to-biological workflow for Ocimum validation. By identifying a high-potency lead with a predicted binding mechanism, these findings move Ocimum from traditional usage into evidence-based antiviral drug discovery. These results provide a strategic blueprint for developing standardized, plant-derived therapeutics against adenoviral infections.

Related

  1. Identification of novel compounds from Olea Europaea targeting hDus2 as potential anticancer agents: a molecular docking and molecular dynamics study
    Monika Mukhija, Anshuman Chandra, Kanika Devi +4
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyFrontiersCrossref
  2. Computational network pharmacology and molecular simulations to explore the potential mechanisms of Pyrrosia piloselloides compounds against prostate cancer.
    Husnul Havid, Ysrafil Ysrafil, Fatmaria Fatmaria +3
    Journal of the Egyptian National Cancer InstitutePeer-reviewedCC BYFull textGeneral medicineEurope PMCPMC
  3. A Structure-Based hERG Pose Selection Workflow Integrating Induced-Fit Docking, Shape Similarity, Interaction Fingerprints, and Molecular Dynamics
    P. Neema, U. Ozuguzel, S. Najafian +1
    bioRxivPreprintAll rights reservedFull textPharmacology & toxicologybioRxiv
  4. Molecular fingerprints linked to graft viability in extended criteria donor livers during normothermic machine perfusion
    Joseph A. Attard, Richard Laing, Lorraine Wallace +24
    Communications MedicinePeer-reviewedCC BY 4.0Full textSurgery & anaesthesiaCrossref
  5. Potential role of resveratrol in abdominal cocoon syndrome: targeting inflammation, oxidative stress, and fibrosis via food-derived bioactive compounds resveratrol for treatment of abdominal cocoon syndrome
    Hailong Guo, Minglei Bi
    Frontiers in pharmacologyPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
BibTeX
@article{refaey2026decoding,
  title = {{Decoding the anti-adenoviral potential of Ocimum volatile organic compounds: linking chemical fingerprints to molecular targets via docking}},
  author = {Mohamed S. Refaey and Miran A. El-Haggar and Omnia Kutkat and Ahmed A. Rashedy and Esraa A. Elhawary},
  journal = {Scientific Reports},
  year = {2026},
  month = oct,
  doi = {10.1038/s41598-026-73287-z},
  url = {https://www.nature.com/articles/s41598-026-73287-z},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Decoding the anti-adenoviral potential of Ocimum volatile organic compounds: linking chemical fingerprints to molecular targets via docking
AU  - Mohamed S. Refaey
AU  - Miran A. El-Haggar
AU  - Omnia Kutkat
AU  - Ahmed A. Rashedy
AU  - Esraa A. Elhawary
PY  - 2026
DA  - 2026/10/21
JO  - Scientific Reports
DO  - 10.1038/s41598-026-73287-z
UR  - https://www.nature.com/articles/s41598-026-73287-z
AB  - Ocimum species are globally recognized for their pharmaceutical utility, yet a comparative mapping of their volatile architecture against viral pathogens remains incomplete. This study evaluated the chemical profiles and antiadenoviral (ADV) potential of Ocimum basilicum (Local), O. basilicum var. minimum (French), and O. africanum (Kafory). Volatiles from three extraction techniques; hydrodistillation, n -hexane, and headspace—were analyzed via GC/MS. One hundred fifty-seven compounds were quantified and subjected to Principal Component Analysis (PCA) and clustered heat mapping. Biological efficacy was assessed via IC ₅₀ determination, supported by molecular docking and molecular dynamics (MD) simulations. PCA effectively discriminated against species, with PC1 and PC2 accounting for 88% of total variance. Oxygenated monoterpenes emerged as the dominant class. Notably, O. africanum hydrodistilled oil exhibited exceptional antiadenoviral potency (IC ₅₀ of 1.72 µ g/ml), significantly outperforming the French (IC ₅₀ of 54.26 µ g/ml) and Local varieties. This superior activity is hypothesized to be linked to the high relative abundance of methyl cinnamate and cadinol, while in silico molecular docking predicted 1,3-dimethyladamantane as a key potential bioactive candidate. MD trajectories (RMSD, RMSF, Rg, and SASA) support the hypothesis that this ligand forms a stable, rigid complex with the viral protein, effectively reducing structural flexibility. This study establishes a high-resolution chemical-to-biological workflow for Ocimum validation. By identifying a high-potency lead with a predicted binding mechanism, these findings move Ocimum from traditional usage into evidence-based antiviral drug discovery. These results provide a strategic blueprint for developing standardized, plant-derived therapeutics against adenoviral infections.
SN  - 2045-2322
ER  -